Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|March 28, 2013
Inhibition of ejaculation by the non-peptide oxytocin receptor antagonist GSK557296: a multi-level site of actionPierre Clément, Jacques Bernabé, Sandrine Compagnie, et al.
The Journal of Sexual Medicine|August 22, 2012
Effect of dapoxetine on ejaculatory performance and related brain neuronal activity in rapid ejaculator ratsPierre Clément, Miguel Laurin, Sandrine Compagnie, et al.
The Journal of Sexual Medicine|July 15, 2006
Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout miceDelphine Behr-Roussel, Benoit Darblade, Alexandra Oudot, et al.
BMC Urology|August 29, 2020
Silodosin improves functional consequences of lower urinary tract obstruction secondary to benign prostate hypertrophy, a proof of concept study in the spontaneously hypertensive rat supplemented with testosteroneRana Assaly, Julie Faugeroux, Miguel Laurin, et al.
Atherosclerosis|May 9, 2002
Distinct mechanisms implicated in atherosclerosis-induced erectile dysfunction in rabbitsDelphine Behr-Roussel, Jacques Bernabe, Sandrine Compagnie, et al.
Psychopharmacology|July 17, 2013
Brain neuronal activation induced by flibanserin treatment in female ratsHelene Gelez, Pierre Clement, Sandrine Compagnie, et al.
The Journal of Sexual Medicine|August 27, 2018
The Favorable Effect of Empagliflozin on Erectile Function in an Experimental Model of Type 2 DiabetesRana Assaly, Diane Gorny, Sandrine Compagnie, et al.
American Journal of Hypertension|September 13, 2008
Impact of a long-term sildenafil treatment on pressor response in conscious rats with insulin resistance and hypertriglyceridemiaDelphine Behr-Roussel, Alexandra Oudot, Sandrine Compagnie, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 7, 2004
Erectile dysfunction: an early marker for hypertension? A longitudinal study in spontaneously hypertensive ratsDelphine Behr-Roussel, Diane Gorny, Katell Mevel, et al.
Toxins|December 24, 2015
Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?Amélie Huynh Le Maux, Bernadette Pignol, Delphine Behr-Roussel, et al.
Pageof 2